Healthcare Payors AI Control Plane Build vs Buy | Moring
The build-versus-buy question for a payor AI control plane resolves around the seams: vendors sell components such as gateways, policy engines, and observability, but the plane must bind to the payor's existing identity, access, and approval systems, which is assembly work. Buying commodity layers and engineering the binding, while the payor owns policy and evidence, avoids rebuilding solved problems and accepting vendor defaults as payor policy.
Short answer
The build-versus-buy question for a payor AI control plane resolves around the seams: vendors sell components such as gateways, policy engines, and observability, but the plane must bind to the payor's existing identity, access, and approval systems, which is assembly work. Buying commodity layers and engineering the binding, while the payor owns policy and evidence, avoids rebuilding solved problems and accepting vendor defaults as payor policy.
How it works
The build-versus-buy question for an AI control plane is distorted by the label itself, because control plane has become a catch-all that every vendor bends toward whatever they already sell: a gateway vendor calls the gateway the plane, an observability vendor calls dashboards the plane, a policy vendor calls rules the plane. Underneath the noise is a real architecture: the part of the system that decides, kept separate from the part that moves. A healthcare payor evaluating options should therefore decompose the question into layers and decide per layer, rather than accepting or rejecting a monolith.
The layers a payor needs are reasonably stable. Identity: registered non-human identities bound to principals. Enforcement: a runtime point where access, tool scope, and approval policy are evaluated between agents and systems of record. Evidence: complete, tamper-evident capture of decisions, actions, and human interventions. Operations: metering, caps, and stop controls. Governing agents in production is three control problems, identity, policy, and evidence, not one, and vendors genuinely strong in one layer are rarely strong in all. The honest evaluation scores candidates per layer against the payor's own workflows: claims, eligibility, clinical documents, and member communications.
The decisive payor-specific constraint is binding to existing systems. A control plane must attach to the payor's current identity, access, and approval infrastructure, because member, provider, and workforce trust anchors already live there, and the plane that cannot bind to them becomes a parallel authority nobody honors. This integration work, connecting the plane to claims platforms, eligibility interfaces, clinical document repositories, and communication channels, is engineering regardless of which product is purchased. Vendors can supply components and reference architectures; the payor supplies the binding, the policy content, and the accountability. Moring's model reflects this reality: the plane is assembled inside the payor environment around its existing identity, access, and approval systems.
Buying pure build carries its own failure mode: commodity layers rebuilt poorly. Gateways, policy evaluation, metering, and evidence storage are solved problems with mature implementations, and a payor that engineers them from scratch spends scarce staff on undifferentiated work while its agents remain ungoverned longer. The workable posture is to buy the commodity layers and build the differentiating ones: the binding to payor systems of record, the policy content that encodes utilization management and claims rules, and the evidence integration with existing audit processes. Ownership stays with the payor, which matters because documentation duties under the EU AI Act attach to the deployer, not the tool vendor.
A decision test clarifies the boundary: for each candidate product, ask what happens when the payor's policy changes tomorrow, and who can prove what the agents did last quarter. If the answer depends on vendor-side configuration the payor cannot inspect or on evidence the payor cannot export, the product is a dependency rather than a plane. Negotiate export, schema stability, and notification of logging changes into the agreement, and stage the deployment so that each new component lands with an agent class already governed, proving the assembly works before scaling it.
Frequently asked questions
Why is the build-versus-buy question hard for AI control planes?
Because control plane has become a catch-all term that vendors bend toward whatever they already sell: gateways, dashboards, or rule engines each get marketed as the plane. The underlying architecture is real, the part that decides kept separate from the part that moves, but it spans identity, policy, and evidence as three distinct control problems. A healthcare payor should decompose the decision per layer and score candidates against its own claims, eligibility, and member communication workflows instead of accepting or rejecting a monolith.
What constraint matters most when a payor buys or builds a control plane?
The plane must bind to the payor's existing identity, access, and approval systems, because trust anchors for member, provider, and workforce relationships already live there, and a plane that cannot bind becomes a parallel authority nobody honors. That binding work, connecting to claims platforms, eligibility interfaces, and clinical document repositories, is engineering regardless of vendor choice. A healthcare payor should budget for it explicitly and retain ownership of policy content and accountability throughout.
Which layers should a payor buy rather than build?
Commodity layers such as gateways, policy evaluation engines, metering, and evidence storage are solved problems with mature implementations, and rebuilding them consumes scarce staff on undifferentiated work while agents stay ungoverned. The differentiating layers to build are the binding to payor systems of record, the policy content encoding utilization management and claims rules, and evidence integration with existing audit processes. Ownership stays with the payor because documentation duties under the EU AI Act attach to the deployer rather than the tool vendor.
What test separates a genuine control plane from a vendor dependency?
Ask two questions of every candidate: what happens when the payor's policy changes tomorrow, and who can prove what the agents did last quarter. If answers depend on vendor-side configuration the payor cannot inspect, or on evidence the payor cannot export, the product is a dependency rather than a plane. A healthcare payor should also negotiate export formats, schema stability, and logging change notifications into agreements, then stage deployments so each component proves itself against an already-governed agent class.